APO RESEARCH · REPORT
Antibody
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
Product & engineering
Understand the product.
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
Selected research
Market Structure
Global Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
Global Monoclonal Antibodies key players include Roche, Johnson and Johnson, Merck, Novartis, AbbVie, etc. Global top five players hold a share about 35%.
North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, having a total share about 45 percent.
Read the full market overview
In terms of product, IgG is the largest segment, with a share about 80%. And in terms of application, the largest application is Research, followed by Therapeutic and Diagnostic.
This report provides an overview of the global Antibody market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Antibody and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Antibody sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antibody market size, projected growth trends, production technologies, key applications, and end-use industries.
Antibody Segment by Company
Roche
Johnson and Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
Antibody Segment by Type
IgM
IgG
IgA
Other
Antibody Segment by Application
Therapeutic
Research
Diagnostic
Antibody Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Antibody market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- IgM
- IgG
- IgA
- Other
Applications
- Therapeutic
- Research
- Diagnostic
Companies covered
- Roche
- Johnson and Johnson
- Merck
- Novartis
- AbbVie
- Amgen
- Pfizer
- Bayer
- Lilly
- Bristol-Myers Squibb
- GlaxoSmithKline
- Biogen
- AstraZeneca
- Sanofi
- Alexion Pharmaceuticals
- Seattle Genetics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Antibody Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Antibody Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Antibody Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Antibody Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Antibody Market Dynamics
- 2.1 Antibody Industry Trends
- 2.2 Antibody Industry Drivers
- 2.3 Antibody Industry Opportunities and Challenges
- 2.4 Antibody Industry Restraints
3 Antibody Market by Manufacturers
- 3.1 Global Antibody Revenue by Manufacturers (2021-2026)
- 3.2 Global Antibody Sales by Manufacturers (2021-2026)
- 3.3 Global Antibody Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Antibody Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Antibody Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Antibody Manufacturers, Product Type & Application
- 3.7 Global Antibody Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Antibody Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Antibody Players Market Share by Revenue in 2025
- 3.8.3 2025 Antibody Tier 1, Tier 2, and Tier 3
4 Antibody Market by Type
- 4.1 Antibody Type Introduction
- 4.1.1 IgM
- 4.1.2 IgG
- 4.1.3 IgA
- 4.1.4 Other
- 4.2 Global Antibody Sales by Type
- 4.2.1 Global Antibody Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Antibody Sales by Type (2021-2032)
- 4.2.3 Global Antibody Sales Market Share by Type (2021-2032)
- 4.3 Global Antibody Revenue by Type
- 4.3.1 Global Antibody Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Antibody Revenue by Type (2021-2032)
- 4.3.3 Global Antibody Revenue Market Share by Type (2021-2032)
5 Antibody Market by Application
- 5.1 Antibody Application Introduction
- 5.1.1 Therapeutic
- 5.1.2 Research
- 5.1.3 Diagnostic
- 5.2 Global Antibody Sales by Application
- 5.2.1 Global Antibody Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Antibody Sales by Application (2021-2032)
- 5.2.3 Global Antibody Sales Market Share by Application (2021-2032)
- 5.3 Global Antibody Revenue by Application
- 5.3.1 Global Antibody Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Antibody Revenue by Application (2021-2032)
- 5.3.3 Global Antibody Revenue Market Share by Application (2021-2032)
6 Global Antibody Sales by Region
- 6.1 Global Antibody Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Antibody Sales by Region (2021-2032)
- 6.2.1 Global Antibody Sales by Region (2021-2026)
- 6.2.2 Global Antibody Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Antibody Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Antibody Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Antibody Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Antibody Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Antibody Revenue by Region
- 7.1 Global Antibody Revenue by Region
- 7.1.1 Global Antibody Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Antibody Revenue by Region (2021-2026)
- 7.1.3 Global Antibody Revenue by Region (2027-2032)
- 7.1.4 Global Antibody Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Antibody Revenue (2021-2032)
- 7.2.2 North America Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Antibody Revenue (2021-2032)
- 7.3.2 Europe Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Antibody Revenue (2021-2032)
- 7.4.2 Asia-Pacific Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Antibody Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Roche
- 8.1.1 Roche Company Information
- 8.1.2 Roche Business Overview
- 8.1.3 Roche Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Roche Antibody Product Portfolio
- 8.1.5 Roche Recent Developments
- 8.2 Johnson and Johnson
- 8.2.1 Johnson and Johnson Company Information
- 8.2.2 Johnson and Johnson Business Overview
- 8.2.3 Johnson and Johnson Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Johnson and Johnson Antibody Product Portfolio
- 8.2.5 Johnson and Johnson Recent Developments
- 8.3 Merck
- 8.3.1 Merck Company Information
- 8.3.2 Merck Business Overview
- 8.3.3 Merck Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Merck Antibody Product Portfolio
- 8.3.5 Merck Recent Developments
- 8.4 Novartis
- 8.4.1 Novartis Company Information
- 8.4.2 Novartis Business Overview
- 8.4.3 Novartis Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Novartis Antibody Product Portfolio
- 8.4.5 Novartis Recent Developments
- 8.5 AbbVie
- 8.5.1 AbbVie Company Information
- 8.5.2 AbbVie Business Overview
- 8.5.3 AbbVie Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 AbbVie Antibody Product Portfolio
- 8.5.5 AbbVie Recent Developments
- 8.6 Amgen
- 8.6.1 Amgen Company Information
- 8.6.2 Amgen Business Overview
- 8.6.3 Amgen Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Amgen Antibody Product Portfolio
- 8.6.5 Amgen Recent Developments
- 8.7 Pfizer
- 8.7.1 Pfizer Company Information
- 8.7.2 Pfizer Business Overview
- 8.7.3 Pfizer Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Pfizer Antibody Product Portfolio
- 8.7.5 Pfizer Recent Developments
- 8.8 Bayer
- 8.8.1 Bayer Company Information
- 8.8.2 Bayer Business Overview
- 8.8.3 Bayer Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Bayer Antibody Product Portfolio
- 8.8.5 Bayer Recent Developments
- 8.9 Lilly
- 8.9.1 Lilly Company Information
- 8.9.2 Lilly Business Overview
- 8.9.3 Lilly Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Lilly Antibody Product Portfolio
- 8.9.5 Lilly Recent Developments
- 8.10 Bristol-Myers Squibb
- 8.10.1 Bristol-Myers Squibb Company Information
- 8.10.2 Bristol-Myers Squibb Business Overview
- 8.10.3 Bristol-Myers Squibb Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Bristol-Myers Squibb Antibody Product Portfolio
- 8.10.5 Bristol-Myers Squibb Recent Developments
- 8.11 GlaxoSmithKline
- 8.11.1 GlaxoSmithKline Company Information
- 8.11.2 GlaxoSmithKline Business Overview
- 8.11.3 GlaxoSmithKline Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 GlaxoSmithKline Antibody Product Portfolio
- 8.11.5 GlaxoSmithKline Recent Developments
- 8.12 Biogen
- 8.12.1 Biogen Company Information
- 8.12.2 Biogen Business Overview
- 8.12.3 Biogen Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Biogen Antibody Product Portfolio
- 8.12.5 Biogen Recent Developments
- 8.13 AstraZeneca
- 8.13.1 AstraZeneca Company Information
- 8.13.2 AstraZeneca Business Overview
- 8.13.3 AstraZeneca Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 AstraZeneca Antibody Product Portfolio
- 8.13.5 AstraZeneca Recent Developments
- 8.14 Sanofi
- 8.14.1 Sanofi Company Information
- 8.14.2 Sanofi Business Overview
- 8.14.3 Sanofi Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Sanofi Antibody Product Portfolio
- 8.14.5 Sanofi Recent Developments
- 8.15 Alexion Pharmaceuticals
- 8.15.1 Alexion Pharmaceuticals Company Information
- 8.15.2 Alexion Pharmaceuticals Business Overview
- 8.15.3 Alexion Pharmaceuticals Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Alexion Pharmaceuticals Antibody Product Portfolio
- 8.15.5 Alexion Pharmaceuticals Recent Developments
- 8.16 Seattle Genetics
- 8.16.1 Seattle Genetics Company Information
- 8.16.2 Seattle Genetics Business Overview
- 8.16.3 Seattle Genetics Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Seattle Genetics Antibody Product Portfolio
- 8.16.5 Seattle Genetics Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Antibody Value Chain Analysis
- 9.1.1 Antibody Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Antibody Production Mode & Process
- 9.2 Antibody Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Antibody Distributors
- 9.2.3 Antibody Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst